Figure 3.

Frequency of AEs, grade≥3, including fatigue (A), vomiting (B), hypertension (C), rash (D) and mucositis (E) among different multiple TKIs.

Note: *p<0.05 and ***p<0.001 indicate statistically significant differences.

Abbreviations: AEs, adverse events; TKIs, tyrosine kinase inhibitors.